Abbott Rapid Diagnostics: what changed
What changed
Abbott Rapid Diagnostics
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
€301,639
2024 · €317,389-€15,751
Equity
€7.1m
2024 · €6.8m+€301,639
Cash
€592,595
2024 · €924,253-€331,658
Balance sheet total
€7.9m
2024 · €8.0m-€49,504
Largest movements
Assets
- Cash -€331,658
down €331,658 (-35.9%), from €924,253 to €592,595
mainly Receivables within one year (-€311,309) and Trade debts (-€276,370)
- Receivables within one year +€311,309
up €311,309 (+4.5%), from €6.9m to €7.3m
of which Other amounts receivable: +€851,462
Equity and liabilities
- Profit (loss) carried forward +€301,639
up €301,639 (+4.5%), from €6.7m to €7.0m
- Trade debts -€276,370
down €276,370 (-43.1%), from €641,568 to €365,198
Income statement
- Goods and materials -€1.2m
down €1.2m (-16.5%), from €7.3m to €6.1m
- Turnover -€955,761
down €955,761 (-10.8%), from €8.9m to €7.9m
- Staff costs +€170,352
up €170,352 (+16.8%), from €1.0m to €1.2m
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€317,389
Turnover
-€955,761
Other operating income
+€6,873
Goods and materials
+€1.2m
Services and other goods
-€39,596
Staff costs
-€170,352
Depreciation
-€30,764
Other operating charges
+€3,283
Financial income
-€70,865
Financial charges
-€84
Taxes
+€34,694
Result 2025
€301,639
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
-€305,716
Investment
-€25,942
Financing
€0
Cash 2024
€924,253
From operations (derived)
-€305,716
Net result for the year
+€301,639
Depreciation
+€55,098
Receivables within one year
-€311,309
Trade debts
-€276,370
Tax, wage and social debts
-€65,121
Accrued charges and deferred income
-€9,652
Investment (derived)
-€25,942
Investment in fixed assets (net)
-€25,942
Cash 2025
€592,595
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,974,492 | €7,924,987 | -€49,504 | -0.6% |
| Fixed assets | 21/28 | €110,159 | €81,004 | -€29,156 | -26.5% |
| Tangible fixed assets | 22/27 | €110,159 | €81,004 | -€29,156 | -26.5% |
| Plant, machinery and equipment | 23 | €109,786 | €81,004 | -€28,783 | -26.2% |
| Furniture and vehicles | 24 | €373 | €0 | -€373 | -100% |
| Financial fixed assets | 28 | €0 | - | = | |
| Other financial fixed assets | 284/8 | €0 | - | = | |
| Amounts receivable and cash guarantees | 285/8 | €0 | - | = | |
| Current assets | 29/58 | €7,864,332 | €7,843,984 | -€20,349 | -0.3% |
| Stocks and contracts in progress | 3 | €0 | €0 | = | |
| Amounts receivable within one year | 40/41 | €6,940,079 | €7,251,388 | +€311,309 | +4.5% |
| Trade receivables | 40 | €2,012,199 | €1,472,046 | -€540,153 | -26.8% |
| Other amounts receivable | 41 | €4,927,880 | €5,779,343 | +€851,462 | +17.3% |
| Cash at bank and in hand | 54/58 | €924,253 | €592,595 | -€331,658 | -35.9% |
| Total equity and liabilities | 10/49 | €7,974,492 | €7,924,987 | -€49,504 | -0.6% |
| Equity | 10/15 | €6,756,106 | €7,057,745 | +€301,639 | +4.5% |
| Contributions | 10/11 | €30,233 | €30,233 | = | 0.0% |
| Profit (loss) carried forward | 14 | €6,725,873 | €7,027,512 | +€301,639 | +4.5% |
| Amounts payable | 17/49 | €1,218,385 | €867,242 | -€351,143 | -28.8% |
| Amounts payable within one year | 42/48 | €1,175,974 | €834,483 | -€341,492 | -29.0% |
| Trade debts | 44 | €641,568 | €365,198 | -€276,370 | -43.1% |
| Suppliers | 440/4 | €641,568 | €365,198 | -€276,370 | -43.1% |
| Taxes, remuneration and social security | 45 | €534,407 | €469,285 | -€65,121 | -12.2% |
| Taxes | 450/3 | €376,615 | €254,204 | -€122,411 | -32.5% |
| Remuneration and social security | 454/9 | €157,791 | €215,081 | +€57,290 | +36.3% |
| Accrued charges and deferred income | 492/3 | €42,411 | €32,759 | -€9,652 | -22.8% |
| Operating income | 70/76A | €8,892,787 | €7,943,899 | -€948,888 | -10.7% |
| Turnover | 70 | €8,876,305 | €7,920,544 | -€955,761 | -10.8% |
| Other operating income | 74 | €16,483 | €23,356 | +€6,873 | +41.7% |
| Operating charges | 60/66A | €8,617,511 | €7,648,119 | -€969,392 | -11.2% |
| Goods for resale, raw materials and consumables | 60 | €7,310,427 | €6,103,605 | -€1.2m | -16.5% |
| Purchases | 600/8 | €7,310,427 | €6,103,605 | -€1.2m | -16.5% |
| Services and other goods | 61 | €242,146 | €281,742 | +€39,596 | +16.4% |
| Remuneration, social security and pensions | 62 | €1,017,023 | €1,187,376 | +€170,352 | +16.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €24,335 | €55,098 | +€30,764 | +126% |
| Other operating charges | 640/8 | €23,581 | €20,298 | -€3,283 | -13.9% |
| Operating profit (loss) | 9901 | €275,276 | €295,780 | +€20,504 | +7.4% |
| Financial income | 75/76B | €190,716 | €119,851 | -€70,865 | -37.2% |
| Recurring financial income | 75 | €190,716 | €119,851 | -€70,865 | -37.2% |
| Income from current assets | 751 | €190,716 | €119,851 | -€70,865 | -37.2% |
| Other financial income | 752/9 | €0 | - | = | |
| Financial charges | 65/66B | €1,765 | €1,849 | +€84 | +4.7% |
| Recurring financial charges | 65 | €1,765 | €1,849 | +€84 | +4.7% |
| Other financial charges | 652/9 | €1,765 | €1,849 | +€84 | +4.7% |
| Profit (loss) for the period before taxes | 9903 | €464,226 | €413,782 | -€50,445 | -10.9% |
| Income taxes | 67/77 | €146,837 | €112,143 | -€34,694 | -23.6% |
| Taxes | 670/3 | €146,837 | €112,143 | -€34,694 | -23.6% |
| Profit (loss) for the period | 9904 | €317,389 | €301,639 | -€15,751 | -5.0% |
| Profit (loss) for the period to be appropriated | 9905 | €317,389 | €301,639 | -€15,751 | -5.0% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.